Assessment of Differential Pharmacodynamic Effects Using Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration

PURPOSE. To use novel OCT parameters in assessing the differential pharmacodynamic effects of bevacizumab (Avastin; Genentech, South San Francisco, CA), pegaptanib (Macugen; OSI Pharmaceuticals, New York, NY), and verteporfin photodynamic therapy (PDT; Novartis, Basel, Switzerland) in a recently com...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Keane, Pearse A., Heussen, Florian M., Ouyang, Yanling, Mokwa, Nils, Walsh, Alexander C., Tufail, Adnan, Sadda, Srinivas R., Patel, Praveen J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Association for Research in Vision and Ophthalmology, Inc. 2012
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3339900/
https://ncbi.nlm.nih.gov/pubmed/22281826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.11-8130
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak